Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancerAmanda Jackson(University of Cincinnati), Victoria Bae‐Jump(University of North Carolina at Chapel Hill)OncotargetOctober 24, 201710.18632/oncotarget.22012Cited by 30SaveCiteExport RISWatch citationsRelated PapersAntiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer|Cancer Medicine|2014|139JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer*|Oncotarget|2015|96Synergistic effect of rapamycin and cisplatin in endometrial cancer cells|Cancer|2009|66Estrogen Induction of Telomerase Activity through Regulation of the Mitogen-Activated Protein Kinase (MAPK) Dependent Pathway in Human Endometrial Cancer Cells|PLoS ONE|2013|46Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer|Cancers|2023|34